We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Aspen Pharmacare

News List

Aspen Pharmacare to manufacture Covid-19 vaccine candidate with J&J pharmaceutical-technology
November 05, 2020
Aspen’s South African subsidiary Aspen Pharmacare has signed a preliminary agreement with two Johnson & Johnson (J&J) subsidiaries for the technical transfer and proposed commercial manufacture of their Covid-19 vaccine candidate.
Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn expresspharma
September 17, 2020
Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS.
Aspen Pharmacare Completes Transfer of AstraZeneca's Anesthetic Medicines Portfolio americanpharmaceuticalreview
August 25, 2017
On Friday, August 18, 2017, Aspen Pharmacare Canada officially completed the transfer of Canadian commercialization rights associated with five of AstraZeneca's anesthetic products.